
The withdrawing of funding from homeopathy in the NHS is welcomed in a letter to this week's BMJ.
In the UK National Health Service, primary care trusts are, quite rightly, withdrawing funding from homeopathy, writes David Colquhoun, Professor of Pharmacology at University College London.
Advertisement
"Something has been done, at last," he says, following news that Tunbridge Wells Homeopathic Hospital will close and the Royal London Homeopathic Hospital is in great danger.
He also supports the view that the US Congress should stop funding the National Center for Complementary and Alternative Medicine (NCCAM).
He points to an article about NCCAM1, which states: "After ten years of existence and over $200 million in expenditures, it has not proved effectiveness for any 'alternative' method. It has added evidence of ineffectiveness of some methods that we knew did not work before NCCAM was formed."
That is something that could be done, he says. The total funding so far for NCCAM approaches $1 billion.
Source: BMJ
VEN/C
He points to an article about NCCAM1, which states: "After ten years of existence and over $200 million in expenditures, it has not proved effectiveness for any 'alternative' method. It has added evidence of ineffectiveness of some methods that we knew did not work before NCCAM was formed."
That is something that could be done, he says. The total funding so far for NCCAM approaches $1 billion.
Source: BMJ
VEN/C
Advertisement
Advertisement
|
Advertisement
Recommended Reading
Latest General Health News

In India, youth must be aware of the diseases linked to cigarette smoking and tobacco consumption, causing a form of healthcare emergency.

Direct coastal access may represent a viable route to public health promotion, but the relationships of coastal living are not strongest among lower-income groups.

New research by Tinnitus UK has found that over four million gardeners are putting their hearing capacity at risk this summer without using safety protection.

Mucus plugs could be targeted to help reduce fatalities from chronic obstructive pulmonary disease.

The development of reliable curative therapies for multiple sclerosis could significantly reduce the economic burden of the disease on patients and wider society.